Epidermal Growth Factor Receptor (EGFR)
|
Assay/ Test |
Epidermal growth factor receptor (EGFR) |
|
Key Words |
EGFR |
|
Specimen Collection |
Technique is possible with 2 sample types 1: Blood sample taken in 2 large red- lidded (EDTA) tube (2 x7.5ml) 2: Formalin fixed Paraffin embedded tissue.
|
|
Turnaround time |
10 days on receipt of request |
|
Test indications |
Used to detect EGFR gene mutations in non-small cell lung cancer tumor cells; knowing whether a mutation is present in the cells can help determine if EGFR-targeted tyrosine kinase inhibitors such as gefitinib and erlotinib may be beneficial for treating the tumor |
|
Interferences |
Although a mutation may be present in the tumor cells, if there is very little tumor tissue and/or when there are insufficient tumor cells present that contain the mutation, the test may result in "no mutation detected" despite the mutation being present in a minority of tumor cells.
Because the amount of tumor DNA in a blood sample is uncertain, testing a blood sample is generally not preferred. However, in situations where insufficient tumor cells are available for molecular testing from a tissue biopsy, or in situations where a tissue biopsy is not able to be taken, a blood test (liquid biopsy) may be an acceptable alternative testing method
|
|
Reference Range |
N/A |
|
N/A |
|
|
N/A |
|
|
|
|



